NCT05504252
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05504252
Title METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin (METIMMOX-2)
Acronym METIMMOX-2
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital, Akershus
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR

Facility Status City State Zip Country Details
Akershus University Hospital Lørenskog Akershus 1478 Norway Details
Oslo University Hospital Oslo Akershus 0424 Norway Details
St Olavs Hospital Trondheim Trøndelag 7006 Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field